Evidence map›Paper›PMID 32122935›Full record

ArticleGenetics2020

Regulation of Nucleolar Dominance in

Natalie Warsinger-Pepe, Duojia Li, Yukiko M Yamashita

Open access · hybridAbstract read
In one paragraph

Article in Genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. International journal of molecular sciences · 2023
    Article
  6. Reaching for the off switch in nucleolar dominance.The Plant journal : for cell and molecular biology · 2023
    Article
  7. The retrotransposon R2 maintainsProceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  8. Article
  9. Under the magnifying glass: The ups and downs of rDNA copy number.Seminars in cell & developmental biology · 2023
    Review
  10. Article
  11. Article
  12. International journal of molecular sciences · 2022
    Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Natalie Warsinger-PepeDepartment of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0002-9375-8990
Duojia LiLife Sciences Institute, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0002-2109-5809
Yukiko M YamashitaLife Sciences Institute, University of Michigan, Ann Arbor, Michigan yukikomy@umich.edu.ORCID 0000-0001-5541-0216
University of Michigan–Ann Arbor · USHoward Hughes Medical Institute · US

Funding

Career Training in Reproductive BiologyT32HD079342 · NICHD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Suzanne M MOENTER · 2014 to 2026
$2.3M
Howard Hughes Medical InstituteNICHD NIH HHS T32 HD079342
6 · The paper itself

Abstract

In eukaryotic genomes, ribosomal RNA (rRNA) genes exist as tandemly repeated clusters, forming ribosomal DNA (rDNA) loci. Each rDNA locus typically contains hundreds of rRNA genes to meet the high demand of ribosome biogenesis. Nucleolar dominance is a phenomenon whereby individual rDNA loci are entirely silenced or transcribed, and is believed to be a mechanism to control rRNA dosage. Nucleolar dominance was originally noted to occur in interspecies hybrids, and has been shown to occur within a species (

Indexed as

Gene Expression Regulation, DevelopmentalGenes, DominantAnimalsCell NucleolusChromosomes, InsectDrosophila melanogasterFemaleMalePolymorphism, Single NucleotideRNA, RibosomalSex ChromosomesSpermatogoniaRNA, RibosomalDrosophilanucleolar dominancerDNA

Identifiers

PMID32122935
PMCPMC7153946
OpenAlexW3009249389

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.